Video
Author(s):
Ross L. Levine, M.D., physician-scientist, director of the Memorial Sloan Kettering (MSK) Center for Hematologic Malignancies and 2016 MPN Hero, discusses the work at his lab that he is currently excited about.
Ross L. Levine, M.D., physician-scientist, director of the Memorial Sloan Kettering (MSK) Center for Hematologic Malignancies and 2016 MPN Hero, discusses the work at his lab that he is currently excited about.
Levine and his team are turning their focus to the JAK2 gene to build on recent successes in the field and hopefully develop some novel approaches. They are also investigating other possible genetic mutations that can be blocked.